fructose 2,6-diphosphate has been researched along with oxidopamine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chau, KY; Hong, CT; Schapira, AH | 1 |
1 other study(ies) available for fructose 2,6-diphosphate and oxidopamine
| Article | Year |
|---|---|
Meclizine-induced enhanced glycolysis is neuroprotective in Parkinson disease cell models.
Topics: Animals; Apoptosis; Cell Line; Fructosediphosphates; Gene Expression Regulation; Glycolysis; Humans; Meclizine; Mice; Mitochondria; Models, Biological; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Phosphofructokinase-2; Phosphofructokinases; Rats | 2016 |